Riddell, Inc. signed a membership interest purchase agreement Simbex, LLC from Evome Medical Technologies Inc. (TSXV:EVMT) for $3.6 million on April 1, 2024. The gross proceeds will reduce senior debt of Simbex by $824,441 upon closing and acquisition debt of the Evome associated with its acquisition of Biodex by $2,115,559, with the remainder of funds used for transaction costs and debt reduction to subordinated and unsecured creditors.
Riddell, Inc. completed the acquisition of Simbex, LLC from Evome Medical Technologies Inc. (TSXV:EVMT) on April 2, 2024.